Playback speed
10 seconds
Management of ALK+ NSCLC Through 1st and Subsequent Lines of Therapy: 2nd Gen ALK TKIs Alectinib & Brigatinib, and BFAST NGS Screening Workflow
163 views
March 18, 2021
Login to view comments.
Click here to Login